Cancer Clinical Trial - HRI HCQ NABPLAGEM-NEO 2020

Status:

Open and enrolling

ClinicalTrials.gov:

NCT04669197

Phase II Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer - CONDITION(S): Pancreatic cancer

Drug

Nab-paclitaxel + Gemcitabine + Cisplatin + Paricalcitol + Hydroxychloroquine

Trial Type

Treatment

Condition

Pancreatic cancer

Keywords

Pancreatic cancer